Filana Therapeutics, Inc. (FLNA) Net income 2016–2025
Filana Therapeutics, Inc. (FLNA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$91.0MFY2025 · since FY2016: -$14.8M → -$91.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$91.0M | -273.7% |
| FY2024 | -$24.3M | +75.0% |
| FY2023 | -$97.2M | -27.5% |
| FY2022 | -$76.2M | -135.4% |
| FY2021 | -$32.4M | -411.3% |
| FY2020 | -$6.3M | -36.8% |
| FY2019 | -$4.6M | +29.4% |
| FY2018 | -$6.6M | +45.0% |
| FY2017 | -$11.9M | +19.8% |
| FY2016 | -$14.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FLNA financial trends
FLNA RevenueFLNA Net marginFLNA Gross profitFLNA Gross marginFLNA Operating incomeFLNA Operating marginFLNA Operating cash flowFLNA Free cash flowFLNA Capital expendituresFLNA Return on equityFLNA Stock buybacksFLNA Dividends paidFLNA Total assetsFLNA Total liabilitiesFLNA Shareholders’ equityFLNA overview →